VolitionRx Limited issued 333,332 shares of common stock to Lind Global Asset Management XII LLC on June 17, 2026, to satisfy a $416,666 payment obligation related to a $7,500,000 senior secured convertible promissory note. This follows a previous issuance of 212,259 shares to the same holder on May 19, 2026, to satisfy another $416,666 obligation. The share issuances were made in reliance on exemptions from registration under the Securities Act. VolitionRx Limited is a biotechnology company.
